By Christine Hall
(CrunchBase News) — Palo Alto, California startup Medable Inc. raised $25 million in funding led by GSR Ventures, to accelerate clinical drug development with digital technology.
Founded in 2015, the company aims to reduce clinical trial timelines by 50 percent through its decentralized trial platform to streamline design, recruitment, retention and the collection of data. Siloed systems are replaced with integrated digital tools, data and interfaces to accelerate trial execution. In addition, Medable connects patients, sites and clinical trial teams to improve patient access, experience and outcomes.
Prior to COVID-19, there were 50,000 active clinical trials, Longmire said. Now, there are 70 clinical trials related to COVID that are going on or are about to be launched.